Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Strategic Planning
  • Published:

In silico drug discovery: Tools for bridging the NCE gap

Nature Biotechnology volume 16, pages 33–34 (1998)Cite this article

Abstract

The infrastructure is now in place for bioinformatics to launch drug discovery on a new growth curve.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A number of pharmaceutical companies have set significant "stretch goals" for their R&D engine in order to generate an ongoing stream of NCEs and double–digit revenue growth rate.

References

  1. Drews, J. 1996.Nature Biotechnology 14:1516–1518.

    Article  CAS  Google Scholar 

  2. The Wilkerson Group recently completed the white paper "Assessment of Informatics Needs and Productivity Bottlenecks in Drug Discovery.".

Download references

Acknowledgements

We would like to acknowledge the help of Judy Korman and George Farrington, managing directors at The Wilkerson Group, for their comments and contributions to this article.

Author information

Authors and Affiliations

  1. a senior consultant focusing on bioinformatics at The Wilkerson Group,

    Bruno L. Larvol

  2. The Wilkerson Group, an IBM company, 590 Madison Avenue, 10th Floor, New York, 10022, NY

    L. John Wilkerson

  3. Galen Associates, New York

    L. John Wilkerson

Authors
  1. Bruno L. Larvol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. John Wilkerson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larvol, B., Wilkerson, L. In silico drug discovery: Tools for bridging the NCE gap. Nat Biotechnol 16 (Suppl 1), 33–34 (1998). https://doi.org/10.1038/5412

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/5412

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing